Benzinga | Nov 24, 2021 06:03AM EST

Morgan Stanley Initiates Coverage On Celularity with Equal-Weight Rating, Announces Price Target of $9

Morgan Stanley analyst Jeffrey Hung initiates coverage on Celularity (NASDAQ:CELU) with a Equal-Weight rating and announces Price Target of $9.